{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:10:03Z","timestamp":1779973803775,"version":"3.53.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA) is frequently observed in biofilm form, exhibiting significant tolerance, particularly in the context of deep tissue infections such as osteomyelitis. This characteristic renders clinical treatment extremely challenging. Therefore, the development of novel antibacterial agents against MRSA and its biofilms is identified as an urgent priority.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      By drug repurposing, this study determines the antibacterial activity of the anti-amoebic small molecule tiliquinol against MRSA and its highly drug-resistant biofilms and evaluates its potential to induce MRSA resistance. The antibacterial mechanism of tiliquinol is examined utilizing transcriptomics, fluorescent probes, and quantitative reverse-transcription polymerase chain reaction. In addition, we evaluate\n                      <jats:italic>in vivo<\/jats:italic>\n                      antibacterial efficacy and safety profiles by established multiple murine infection models, including skin and soft tissue infection, sepsis, as well as the periprosthetic joint infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The research find that tiliquinol exhibits notable antibacterial activity against MRSA and its highly resistant biofilms avoiding resistance occurrence. Mechanism study reveals that the proton motive force and peptidoglycan are potential therapeutic targets by tiliquinol. Further, in various mouse infection models, favorable\n                      <jats:italic>in vivo<\/jats:italic>\n                      antibacterial efficacy with satisfied safety profiles of tiliquinol are confirmed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tiliquinol is recognized as a novel therapeutic strategy against refractory MRSA-related infections, particularly those associated with osteomyelitis and implant-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1851763","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:22:26Z","timestamp":1779970946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug repurposing: a dual-mechanism antibiotic combats MRSA and its high resistant phenotypes"],"prefix":"10.3389","volume":"16","author":[{"given":"Pengfei","family":"She","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Graduate Collaborative Training Base of The First Hospital of Changsha, of Hengyang Medical College, University of South China","place":["Hengyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Department of Laboratory Medicine, The Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Graduate Collaborative Training Base of The First Hospital of Changsha, of Hengyang Medical College, University of South China","place":["Hengyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Department of Laboratory Medicine, The Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Department of Laboratory Medicine, The Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Graduate Collaborative Training Base of The First Hospital of Changsha, of Hengyang Medical College, University of South China","place":["Hengyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelan","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Graduate Collaborative Training Base of The First Hospital of Changsha, of Hengyang Medical College, University of South China","place":["Hengyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University)","place":["Changsha, China"]},{"name":"Graduate Collaborative Training Base of The First Hospital of Changsha, of Hengyang Medical College, University of South China","place":["Hengyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00327","article-title":"Lipoteichoic acid inhibits Staphylococcus aureus biofilm formation","volume":"9","author":"Ahn","year":"2018","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1128\/aac.00603-08","article-title":"Ultrastructural effects of oritavancin on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus","volume":"53","author":"Belley","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/ph18081217","article-title":"Oritavancin a therapeutic option for periprosthetic joint infections in selected cases: a comprehensive review","volume":"18","author":"Birlutiu","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B4","first-page":"136","article-title":"Resistance of Vibrio cholerae 0:1 to the 0\/129 compound and multiresistance to antibiotics","volume":"85","author":"Bougoudogo","year":"1992","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"B5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"B6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2125.2011.04128.x","article-title":"Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application","volume":"73","author":"Dancik","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1179\/2047773213y.0000000121","article-title":"Unusual multiple large abscesses of the liver: interest of the radiological features and the real-time PCR to distinguish between bacterial and amebic etiologies","volume":"108","author":"Desoubeaux","year":"2014","journal-title":"Pathog. Glob. Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01801-21","article-title":"Staphylococcal bacterial persister cells, biofilms, and intracellular infection are disrupted by JD1, a membrane-damaging small molecule","volume":"12","author":"Dombach","year":"2021","journal-title":"mBio"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/nyas.14541","article-title":"Understanding tolerance to cell wall-active antibiotics","volume":"1496","author":"D\u00f6rr","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01711-17","article-title":"Efficacy of tilorone dihydrochloride against Ebola virus infection","volume":"62","author":"Ekins","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","article-title":"Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus","volume":"20","author":"Farha","year":"2013","journal-title":"Chem. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"108550","DOI":"10.1016\/j.pharmthera.2023.108550","article-title":"Multitarget antibacterial drugs: an effective strategy to combat bacterial resistance","volume":"28","author":"Feng","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jgar.2014.04.006","article-title":"Vancomycin-intermediate resistance in Staphylococcus aureus","volume":"2","author":"Hiramatsu","year":"2014","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1099\/jmm.0.000585","article-title":"Borderline oxacillin-resistant Staphylococcus aureus (BORSA) -a more common problem than expected","volume":"66","author":"Hryniewicz","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2475841","article-title":"Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern China","volume":"14","author":"Hu","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147602","article-title":"Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies","volume":"18","author":"Idrees","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1021\/acscentsci.3c00499","article-title":"Repurposed fenoprofen targeting SaeR attenuates Staphylococcus aureus virulence in implant-associated infections","volume":"9","author":"Jiang","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00253-022-12356-5","article-title":"Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus","volume":"107","author":"Katsipis","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13010076","article-title":"Biofilm producing methicillin-resistant Staphylococcus aureus (MRSA) infections in humans: clinical implications and management","volume":"13","author":"Kaushik","year":"2024","journal-title":"Pathogens"},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature26157","article-title":"A new class of synthetic retinoid antibiotics effective against bacterial persisters","volume":"556","author":"Kim","year":"2018","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115160","article-title":"Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy","volume":"250","author":"Kokot","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13121151","article-title":"Prevention and modern strategies for managing methicillin-resistant staphylococcal infections in prosthetic joint infections (PJIs)","volume":"13","author":"Kraus","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pathogens2020288","article-title":"From in vitro to in vivo models of bacterial biofilm-related infections","volume":"2","author":"Lebeaux","year":"2013","journal-title":"Pathogens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.132410","article-title":"Antimicrobial activity of cyanidin-3-O-glucoside-lauric acid ester against Staphylococcus aureus and Escherichia coli","volume":"383","author":"Li","year":"2022","journal-title":"Food Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00253-022-11878-2","article-title":"Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA","volume":"106","author":"Li","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxac023","article-title":"Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype","volume":"134","author":"Li","year":"2023","journal-title":"J. Appl. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030557","article-title":"Clinical impact of Staphylococcus aureus skin and soft tissue infections","volume":"12","author":"Linz","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.1","article-title":"Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains","volume":"4","author":"Liu","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn7006","article-title":"ECM-mimetic immunomodulatory hydrogel for methicillin-resistant Staphylococcus aureus-infected chronic skin wound healing","volume":"8","author":"Liu","year":"2022","journal-title":"Sci. Adv."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902227","article-title":"Metformin restores tetracyclines susceptibility against multidrug resistant bacteria","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci. (Weinh)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.727692","article-title":"Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158088","article-title":"Molecular mechanisms of drug resistance in Staphylococcus aureus","volume":"23","author":"Mlynarczyk-Bonikowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02024-22","article-title":"Proton motive force inhibitors are detrimental to methicillin-resistant Staphylococcus aureus strains","volume":"10","author":"Mohiuddin","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1186\/s12879-025-11350-2","article-title":"Exploring the incidence potential of phenol-soluble modulins among methicillin-resistant Staphylococcus aureus in Lahore, Pakistan","volume":"25","author":"Mudassar","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3791\/2437","article-title":"Microtiter dish biofilm formation assay","volume":"30","author":"O'Toole","year":"2011","journal-title":"J. Vis. Exp"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2208901","article-title":"Gram-negative quorum sensing signalling enhances biofilm formation and virulence traits in gram-positive pathogen Enterococcus faecalis","volume":"15","author":"Parga","year":"2023","journal-title":"J. Oral. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010012","article-title":"A review of biofilm formation of Staphylococcus aureus and its regulation mechanism","volume":"12","author":"Peng","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00018-022-04588-5","article-title":"L007\u20130069 kills Staphylococcus aureus in high resistant phenotypes","volume":"79","author":"Pengfei","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70046","article-title":"Novel antibiotics against Staphylococcus aureus without detectable resistance by targeting proton motive force and FtsH","volume":"6","author":"Pengfei","year":"2025","journal-title":"MedComm (2020)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13568-024-01809-x","article-title":"Repurposing pinaverium bromide against Staphylococcus and its biofilms with new mechanisms","volume":"14","author":"Pengfei","year":"2024","journal-title":"AMB Express"},{"key":"B45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.celrep.2019.12.033","article-title":"Dual RNA-Seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions","volume":"30","author":"Pisu","year":"2020","journal-title":"Cell Rep."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.907314","article-title":"Bacteriophage therapy for Staphylococcus aureus infections: a review of animal models, treatments, and clinical trials","volume":"12","author":"Plumet","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050924","article-title":"Rapid detection of Escherichia coli antibiotic susceptibility using live\/dead spectrometry for lytic agents","volume":"9","author":"Robertson","year":"2021","journal-title":"Microorganisms"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01623-23","article-title":"Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions","volume":"63","author":"Schuetz","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00425-25","article-title":"Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant Enterococcus membranes","volume":"10","author":"She","year":"2025","journal-title":"mSystems"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02114-22","article-title":"Pixantrone sensitizes Gram-negative pathogens to rifampin","volume":"10","author":"She","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acsinfecdis.3c00737","article-title":"Lusutrombopag as a repurposing drug in combination with aminoglycosides against vancomycin-resistant Enterococcus","volume":"10","author":"She","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01026-23","article-title":"Repurposing of the antimalarial agent tafenoquine to combat MRSA","volume":"8","author":"She","year":"2023","journal-title":"mSystems"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5194\/jbji-10-101-2025","article-title":"Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone\u2009&\u2009Joint Infection Society (EBJIS)","volume":"10","author":"Sigmund","year":"2025","journal-title":"J. Bone Jt Infect."},{"key":"B54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41586-018-0483-6","article-title":"Optimized arylomycins are a new class of Gram-negative antibiotics","volume":"561","author":"Smith","year":"2018","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(83)92000-7","article-title":"Oxyquinoline toxicity","volume":"1","author":"Soffer","year":"1983","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100749","article-title":"Plant natural flavonoids against multidrug resistant pathogens","volume":"8","author":"Song","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cell.2020.04.001","article-title":"A deep learning approach to antibiotic discovery","volume":"181","author":"Stokes","year":"2020","journal-title":"Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s42770-021-00547-7","article-title":"Australian propolis ethanol extract exerts antibacterial activity against methicillin-resistant Staphylococcus aureus by mechanisms of disrupting cell structure, reversing resistance, and resisting biofilm","volume":"52","author":"Wang","year":"2021","journal-title":"Braz. J. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.688772","article-title":"Repurposing candesartan cilexetil as antibacterial agent for MRSA infection","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/med.21946","article-title":"Bacterial proton motive force as an unprecedented target to control antimicrobial resistance","volume":"43","author":"Yang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1038\/s41598-025-95559-w","article-title":"Analysis of cellular responses following interaction with extracellular vesicles derived from HEK293T and human adipose derived stem cells","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100681","article-title":"Diclofenac resensitizes methicillin-resistant Staphylococcus aureus to \u03b2-lactams and prevents implant infections","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2023.100117","article-title":"Berberine disrupts staphylococcal proton motive force to cause potent anti-staphylococcal effects in vitro","volume":"5","author":"Zhao","year":"2023","journal-title":"Biofilm"},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2016.08.027","article-title":"Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo","volume":"52","author":"Zhao","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jare.2025.08.001","article-title":"Emerging host-directed strategies for overcoming drug resistance and immune evasion in Staphylococcus aureus infections","volume":"83","author":"Zheng","year":"2026","journal-title":"J. Adv. Res."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2321981","article-title":"AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria","volume":"13","author":"Zheng","year":"2024","journal-title":"Emerg. Microbes Infect."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1851763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:22:27Z","timestamp":1779970947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1851763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":66,"alternative-id":["10.3389\/fcimb.2026.1851763"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1851763","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1851763"}}